| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, Virginia 23298 [J. W. L., L. F. P.], and Department of Cell and Molecular Biology, Lawrence Berkeley National Laboratory, Berkeley, California 94720 [S. M. Y., D. J. C.]
| ABSTRACT |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
|
| Materials and Methods |
|---|
|
|
|---|
End-joining Reactions.
Extracts (12.5 mg/ml protein) were dialyzed for 30 min against a mixture of 50 mM morpholinoethanesulfonate, NaOH (pH 7.5), 40 mM KCl, 10 mM MgCl2, and 5 mM ß-mercaptoethanol immediately before use. End-joining reactions contained 11 µl of extract, 1 mM ATP, 50 µM dNTP or dideoxynucleoside 5'-triphosphate (ddNTP), 50 µg/ml BSA, and 10 ng of substrate in a total volume of 13 µl. Reactions were incubated for 6 h at 25°C and deproteinized by treatment with proteinase K followed by phenol extraction. DNA was cut with BstXI and XhoI and analyzed on sequencing gels as described previously (3)
.
| Results |
|---|
|
|
|---|
ACGT. Accurate restoration of the original sequence would require PG removal, alignment of the self-complementary CG overhangs, fill-in of the one-base gaps with dTTP, and ligation (Fig. 1)
Extracts of CHO-K1 cells were able to repair this model free-radical-mediated DSB (Fig. 2)
, yielding a prominent repair product corresponding to accurate restoration of the original sequence, which was detected as a 43-base fragment after XhoI/BstXI cleavage (3)
. Previous studies (3)
showed that this process is strictly dependent on Ku, suggesting that it reflects, at least to some degree, end-joining repair as it occurs in vivo. Additional
2324 base products were also detected, which may have resulted from resection-based end joining (1)
. They were apparently not head-to-head intermolecular end-joining products, because they were not present when DNA was cut with XhoI alone (data not shown). Curiously, supplementation of CHO-K1 extracts with XRCC4/ligase IV (Fig. 2
, Lane 5) resulted in additional, as yet unidentified, end-joining products that appeared to be even longer than the accurate product.
|
,
, and
(10)
, did not prevent either accurate end joining or gap filling (Fig. 2
, and µ (11)
. The apparent conflict between these data and a report that aphidicolin partially inhibits the generation of gap-filling-dependent end-joining products (12)
remains to be resolved.
XR-1 cells are genetically deficient in XRCC4, and because DNA ligase IV is unstable in the absence of XRCC4, XR-1 extracts lack both XRCC4 and ligase IV (13)
. Thus, as expected, no end-joining products at all were detected when the same DSB substrate was incubated in XR-1 extracts (Fig. 3A
, Lanes 12). To determine whether this end joining deficiency was caused by the absence of XRCC4/ligase IV or to some other property of the extracts, XR-1 extracts were supplemented with exogenous recombinant XRCC4/ligase IV. XRCC4/ligase IV, either obtained commercially (Fig. 3
, Lane 3) or prepared in-house (Lane 7), restored accurate end joining to the XR-1 extracts. These results suggest that the XR-1 extracts were fully competent for DNA end joining, except for the lack of XRCC4/ligase IV.
|
Although DNA ligase IV is stable only in the presence of XRCC4 (13)
, XRCC4 is stable in the absence of ligase IV.4
To determine whether XRCC4 alone was sufficient to support alignment-based gap filling, XR-1 cells were supplemented with recombinant XRCC4. As shown in Fig. 3B
, however, no gap filling was detected in XR-1 extracts supplemented with XRCC4 alone, implying that gap filling requires both XRCC4 and DNA ligase IV.
| Discussion |
|---|
|
|
|---|
Most naturally occurring DSBs, such as those resulting from free radicals, have missing, fragmented, or damaged nucleotides that will preclude repair by simple religation. Either these nucleotides must be replaced by a gap-filling mechanism, potentially allowing restoration of the original sequence, or the damaged ends must be trimmed to produce a ligatable substrate, resulting in a small deletion. At least in vitro, it appears that Ku-dependent end joining normally restores the original sequence by gap filling, as long as the ends have overhangs with residual complementarity, even as little as 2 bp (3) . In the case of 3' overhangs, such gap-filling requires prior alignment of the ends, presumably based on the annealing of the residual complementarity. X-ray crystallography of Ku bound to a DNA end shows that Ku forms a tightly fitting asymmetrical ring around DNA, suggesting that Ku could cradle two DNA ends and mold them into a continuous helix while, nevertheless, allowing access to the DNA termini on one side of the ring (15) . In vitro end-joining studies (3 , 16) imply that Ku is essential for alignment during gap filling but do not indicate whether Ku is sufficient for this function. The present results suggest that gap filling also requires the XRCC4/ligase IV complex, at least under conditions of the in vitro assay.
Recently, it was shown that DNA polymerase µ binds to XRCC4/ligase IV and stabilizes complexes between XRCC4/ligase IV and DNA, and that the combination of Ku, XRCC4/ligase IV, and polymerase µ could effect fill-in and ligation of a substrate with cohesive 4-base hydroxyl-terminated 3' overhangs and a one-base gap in one strand (9) . Although these studies did not explicitly address the question of whether XRCC4/ligase IV was required for gap filling, they provided further indirect evidence for such a requirement. They also suggested that the requirement for XRCC4/ligase IV in gap filling could be attributable, in part, to its role in recruiting polymerase µ to the aligned ends. XRCC4/ligase IV also probably helps to stabilize Ku-mediated DNA end-to-end association, as XRCC4/ligase IV itself promotes end-to-end association (17) . All of these results, as well as the data presented above, suggest that both gap filling and ligation are carried out in the context of a repair complex that includes Ku, XRCC4, ligase IV, and polymerase µ. In neither experimental system, however, does DNA-PKcs appear to be required for these processes (3 , 9) . A key remaining question is how the putative complex of Ku, polymerase µ, and XRCC4/ligase IV sequentially affords access of the DNA termini to processing by polymerase µ and then by ligase IV, presumably even while Ku continues to bind to and align the two DNA ends.
| FOOTNOTES |
|---|
1 Supported by Grants CA40615 and CA50519 from the National Cancer Institute, United States Department of Health and Human Services, and by Contract DE-AC03-76SF00098 from the United States Department of Energy. ![]()
2 To whom requests for reprints should be addressed, at Department of Pharmacology and Toxicology Virginia Commonwealth University, P. O. Box 980230, Richmond, VA 23298-0230. E-mail: LPOVIRK{at}hsc.vcu.edu ![]()
3 The abbreviations used are: DSB, double-strand break; DNA-PK, DNA-dependent protein kinase; PG, phosphoglycolate; dNTP, deoxynucleoside triphosphate. ![]()
4 S. M. Yannone, unpublished observations. ![]()
Received 9/23/02. Accepted 11/12/02.
| REFERENCES |
|---|
|
|
|---|
, a novel DNA repair enzyme in human cells. J. Biol. Chem., 277: 13184-13191, 2002.This article has been cited by other articles:
![]() |
L. Schulte-Uentrop, R. A. El-Awady, L. Schliecker, H. Willers, and J. Dahm-Daphi Distinct roles of XRCC4 and Ku80 in non-homologous end-joining of endonuclease- and ionizing radiation-induced DNA double-strand breaks Nucleic Acids Res., May 1, 2008; 36(8): 2561 - 2569. [Abstract] [Full Text] [PDF] |
||||
![]() |
R.-Z. Zhou, L. Blanco, M. Garcia-Diaz, K. Bebenek, T. A. Kunkel, and L. F. Povirk Tolerance for 8-oxoguanine but not thymine glycol in alignment-based gap filling of partially complementary double-strand break ends by DNA polymerase {lambda} in human nuclear extracts Nucleic Acids Res., May 1, 2008; 36(9): 2895 - 2905. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kuhfittig-Kulle, E. Feldmann, A. Odersky, A. Kuliczkowska, W. Goedecke, A. Eggert, and P. Pfeiffer The mutagenic potential of non-homologous end joining in the absence of the NHEJ core factors Ku70/80, DNA-PKcs and XRCC4-LigIV Mutagenesis, May 1, 2007; 22(3): 217 - 233. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Despras, P. Pfeiffer, B. Salles, P. Calsou, S. Kuhfittig-Kulle, J. F. Angulo, and D. S.F. Biard Long-term XPC Silencing Reduces DNA Double-Strand Break Repair Cancer Res., March 15, 2007; 67(6): 2526 - 2534. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Jones, D. A. Gewirtz, S. M. Yannone, S. Zhou, D. G. Schatz, K. Valerie, and L. F. Povirk Radiosensitization of MDA-MB-231 breast tumor cells by adenovirus-mediated overexpression of a fragment of the XRCC4 protein Mol. Cancer Ther., October 1, 2005; 4(10): 1541 - 1547. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Pan-Hammarstrom, A.-M. Jones, A. Lahdesmaki, W. Zhou, R. A. Gatti, L. Hammarstrom, A. R. Gennery, and M. R. Ehrenstein Impact of DNA ligase IV on nonhomologous end joining pathways during class switch recombination in human cells J. Exp. Med., January 18, 2005; 201(2): 189 - 194. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. McVey, D. Radut, and J. J. Sekelsky End-Joining Repair of Double-Strand Breaks in Drosophila melanogaster Is Largely DNA Ligase IV Independent Genetics, December 1, 2004; 168(4): 2067 - 2076. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Lee, L. Blanco, T. Zhou, M. Garcia-Diaz, K. Bebenek, T. A. Kunkel, Z. Wang, and L. F. Povirk Implication of DNA Polymerase {lambda} in Alignment-based Gap Filling for Nonhomologous DNA End Joining in Human Nuclear Extracts J. Biol. Chem., January 2, 2004; 279(1): 805 - 811. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Bebenek, M. Garcia-Diaz, L. Blanco, and T. A. Kunkel The Frameshift Infidelity of Human DNA Polymerase {lambda}: IMPLICATIONS FOR FUNCTION J. Biol. Chem., September 5, 2003; 278(36): 34685 - 34690. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |